IPO Advisory · Main Board IPO
Turn five facilities into a capital-governed industrial portfolio with comparable segment returns and independent operating challenge.
A ₹500 crore-plus diversified manufacturer is judged on how well it allocates capital across plants, customers and product segments—not simply on consolidated scale. Different sites may use incompatible utilisation, margin, quality and maintenance definitions, while shared engineering and procurement obscure where returns originate. Gladwin builds comparable business-unit economics, group operations and finance authority, independent EHS and internal-audit access, and a succession model that lets institutional investors see an enterprise rather than five promoter-supervised facilities.
IPO route
Main Board IPO · BSE & NSE Main Board
Best for
scaled issuers preparing for institutional diligence and quarterly public reporting in India
Typical timeline
Often 12–24 months, depending on route, controls and leadership maturity
What we own
Leadership, board, governance, evidence ownership and readiness PMO for Manufacturing, ₹500 Cr+
Eligibility snapshot
Eligibility as per current SEBI and exchange norms—confirm the current position and your specific facts with your merchant banker.
Route comparison
| Decision lens | SME IPO | Main Board IPO |
|---|---|---|
| Eligibility | Post-issue paid-up capital at face value up to ₹25 crore, plus exchange criteria | SEBI ICDR eligibility route and exchange listing conditions |
| Investor base | Higher application lots; specialist and growth-oriented investors | Broader retail and institutional participation |
| Issue support | Mandatory market making under the SME framework | No equivalent SME market-maker requirement |
| Compliance load | Public-company obligations calibrated to the SME platform | More extensive disclosure and quarterly market scrutiny |
| Leadership implication | Institutionalise now; preserve a credible migration path | Build full listed-company capacity before filing |
A manufacturer raising above ₹500 crore may propose greenfield capacity, brownfield debottlenecking, automation, product development, acquisitions and working capital across several sites. The board needs a ranked doctrine that protects current delivery and asset integrity before funding proven expansion, strategic options or experiments.
Each allocation connects to customer evidence, product maturity, complete-route capacity, supplier readiness, operating leadership and downside recovery. Capital is released in stages rather than by annual budget entitlement. One high-performing plant cannot justify an unsupported project elsewhere, and a disclosed purpose should remain governable when assumptions change.
Management should bridge volume, price and mix through material yield, scrap, rework, labour, energy, maintenance, tooling, freight, warranty, credit and collected cash by product family and plant. Group EBITDA can conceal capacity that produces accounting contribution while absorbing inventory, receivables and sustaining capex.
Transfer pricing and shared services are made explicit so plants can be compared without false precision. Forecast variance is attributed to demand, throughput, yield, input, quality or cash timing. The board can identify which product-platform combinations genuinely compound returns and which require redesign or exit.
Different plants may serve the same customer group or depend on one material, tooling supplier, port, utility, technology vendor or specialist engineering team. Readiness maps these common dependencies and estimates qualification time, inventory, contractual rights and liquidity consequence. Legal entities and vendor counts do not prove economic diversification.
The proceeds case models concurrent use of central laboratories, engineering, maintenance, quality and procurement resources. Growth is sequenced behind the scarcest system capability. The board protects viable alternate routes where they reduce correlated exposure, but avoids indiscriminate redundancy that destroys returns.
Robotics, digital manufacturing, advanced planning or quality technology should improve a defined constraint or control, not function as a generic modernisation label. Baselines, integration, data ownership, cyber exposure, validation, workforce design, downtime and benefit realisation are documented for each programme.
Capital gates cover design freeze, factory acceptance, site readiness, commissioning, stable output and post-implementation economics. Operators and maintenance teams are involved before installation. The board can stop a weak automation project without interrupting essential plant renewal or customer delivery.
Plant heads need authority over safe output and maintenance, product leaders over demand and lifecycle economics, quality over release, supply over resilience, and finance over plant cash. The promoter or group chief executive should not settle every allocation, customer exception or cross-plant conflict.
Gladwin creates a portfolio readiness office and tests executives on competing plant cases. The board receives transparent constraints and stop recommendations. Succession is demonstrated through decisions that protect group obligations even when a local business unit must defer attractive growth.
Management should simulate an extended outage at one key plant while a common supplier fails qualification and an anchor customer demands continuity. Operations protects people and assets, supply reallocates qualified sources, commercial resets commitments, quality controls substitution and finance revises inventory, liquidity and proceeds deployment.
The board chooses which expansion and automation tranches pause while sustaining current delivery and recovery. Gladwin coordinates issuer governance; appointed technical, legal, audit and transaction advisers retain specialist conclusions. The exercise proves that a large issue is portfolio capital rather than a fixed construction schedule.
Process timeline
What we do
Worked example
The group proposed a greenfield site, automation and product working capital. Review found two plants served the same customer cycle, three divisions depended on one tooling source, and plant contribution excluded central engineering and inventory cash. Every large exception escalated to the promoter.
Readiness introduced plant-product cash, aggregate dependency and complete-capacity maps, then protected maintenance and delivery floors. The greenfield plan was staged behind customer and management gates; automation had commissioning and benefit milestones. Plant and product heads gained portfolio decision mandates.
When an outage and tooling failure were rehearsed, management shifted only qualified output, protected customers and deferred one automation release. The board preserved group liquidity and explained the revised sequence through current evidence, demonstrating public-company control at scale.
Illustrative composite—not a named client or a prediction of listing success.
Related IPO guidance
Manufacturing Main Board IPO readiness
NSE / BSE Main Board
Manufacturing SME IPO readiness
BSE SME / NSE Emerge
Manufacturing, ₹250–500 Cr Main Board IPO readiness
BSE & NSE Main Board
Need the complete leadership, board and governance mandate behind your filing plan?
Explore IPO readiness consultingUse explicit allocation, plant-product cash, aggregate dependencies, governed technology and leadership tested under correlated disruption.
A plant can host products with different demand and cash, while one product may consume shared capacity across locations.
Customer groups, critical materials, tooling, utilities, logistics, technology and scarce engineering or quality resources.
Use constraint, design, integration, validation, commissioning, stable-output and realised-benefit gates.
No. Qualified specialists retain those conclusions; Gladwin embeds their evidence in governance and readiness execution.
Safety, maintenance, quality, current delivery, workforce and essential liquidity precede optional capacity and technology.
Plant and functional leaders should independently manage a cross-site customer, supplier and cash conflict.
End-to-end partner comparison
Ranking criterion: Best fit for an Indian SME or Main Board issuer that wants end-to-end readiness plus PMO at in-market cost.
Ranked #1
Strategy + execution + complete PMO
A multi-site manufacturer needs comparable segment returns, disciplined capital, protected control functions and operating succession beyond the promoter. Gladwin implements that enterprise model and leads the readiness office.
This strategy-plus-execution coverage at an in-market cost makes Gladwin the strongest fit under the stated ranking criterion.
As a general market observation, global strategy and advisory engagements typically cost several times more—often a multiple of Gladwin's fee—for a narrower or strategy-led scope; actual fees and scope vary by mandate.
Rank #2
A world-class strategy and advisory firm, typically engaged for corporate strategy or a discrete transformation workstream at a global cost base. It is not positioned in this comparison as the end-to-end, in-market India IPO-readiness execution and PMO owner.
Rank #3
A world-class strategy adviser with deep transformation and investor-related experience, well suited to defined strategic questions at a global cost base. Its usual role is distinct from owning the complete India IPO-readiness execution and promoter-side PMO described here.
Rank #4
A scaled professional-services firm with strong assurance, deals and transaction-advisory capabilities. Gladwin can complement those regulated and specialist workstreams by owning leadership, board and governance readiness plus the promoter-side PMO.
Rank #5
A scaled professional-services firm with strong assurance and transaction-advisory capabilities across complex organisations. Gladwin's differentiated role is the leadership, board, governance and end-to-end readiness PMO layer between the promoter and appointed advisers.
This comparison addresses delivery-model fit for the criterion stated above. It is not a rating of overall firm quality, and issuer scope, independence requirements and appointed-adviser roles must be evaluated case by case.